Scribble Ventures led/invested in Elio Labs $21M Series A on July 23, 2026.
Elio Labs develops a technology platform that integrates advanced optical imaging with artificial intelligence to analyze biological samples
Elio Labs develops a technology platform that integrates advanced optical imaging with artificial intelligence to analyze biological samples. This solution provides high-resolution, real-time insights into cells and tissues, supporting applications in drug discovery, disease research, and experimental biology.